General Information of Drug (ID:
DR3428) |
Drug Name |
BMS-582664
|
Prodrug Info |
BMS-582664 is the prodrug of Brivanib
|
Synonyms |
Brivanib alaninate; BMS 582664; BMS582664; BMS-582664, Brivanib alaninate; Brivanib alaninate (INN/USAN); L-Alanine, (1R)-2-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl ester
|
Indication |
Hepatocellular carcinoma
[ICD11: 2C12]
|
Phase 3
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
441.5 |
Topological Polar Surface Area |
117 |
Heavy Atom Count |
32 |
Rotatable Bond Count |
8 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 11154925
- CAS Number
-
- TTD Drug ID
- D03WQS
- Formula
- C22H24FN5O4
- Canonical SMILES
- CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C
- InChI
- InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1
- InChIKey
- LTEJRLHKIYCEOX-OCCSQVGLSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.